ProKidney’s Progress in FDA Approval and Financial Health
Prokidney Corp. ( (PROK) ) has released its Q3 earnings. Here is a breakdown of the information Prokidney Corp. presented to its investors.
Business Insider1d
ProKidney’s Future: Balancing Promising FDA Developments with Financial Uncertainties
The company’s recent communication with the FDA suggests promising developments ... Read More on PROK: Prokidney Corporation Registered Shs NewsMORE Related Stocks Indices Commodities Currencies ...
US FDA declines full approval for Intercept's liver disease drug
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Business Insider8y
FDA sends a warning letter to Whole Foods
An envelope. It indicates the ability to send an email. Whole Foods was sent a warning letter from the FDA regarding safety violations in their Everett, Massachusetts food prep facility.
Reuters7h
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder
Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy that ...
Business Insider1y
FDA approves first over-the-counter birth control pill in the US
An envelope. It indicates the ability to send an email. The first over-the-counter birth control pill has been approved by the FDA. Opill has been in use for over 50 years and has a 93% effective ...
CNN6d
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The FDA’s proposal isn’t an immediate order; it launches a six-month public comment period, after which the agency will make a final decision on whether to pull it from shelves.
U.S. News & World Report29d
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now By Robin Foster HealthDay Reporter TUESDAY, Oct. 15, 2024 (HealthDay News) -- Pharmacists may continue making ...
U.S. News & World Report6d
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
THURSDAY, Nov. 7, 2024 (HealthDay News) -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug ...